Support The Show On Patreon!:
Subscribe to Krystal Kyle & Friends On Substack!:
Scientists and researchers have long tried to prove that psychedelic drugs could treat some of the most intractable problems in human health, like addiction and post-traumatic stress disorder (PTSD). Now, they have data to back their claims, paving the way for the bourgeoning psychedelics market.
On Monday, the journal Nature published the phase-III clinical trial results on MDMA-assisted psychotherapy as a treatment for PTSD, operated by the Multidisciplinary Association of Psychedelic Studies (MAPS). The data is impressive. After 18 weeks and three sessions, 67% of participants receiving MDMA therapy saw so much symptom reduction that they no longer met the threshold for a PTSD diagnosis.
Follow Kyle on Twitter: